Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences Inc
(NQ:
ENSC
)
0.3678
-0.0165 (-4.29%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Aug 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ensysce Biosciences Inc
< Previous
1
2
3
4
Next >
Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform
June 27, 2022
SAN DIEGO, CA / ACCESSWIRE / June 27, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC) (OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting
June 21, 2022
- Shareholder Meeting to be Held on Thursday, June 23rd at 9:00 AM PT
From
Ensysce Biosciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
May 23, 2022
~ Nasal Opioid Abuse Being Explored for PF614 ~
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
May 12, 2022
Corporate Update Call to be Held Tuesday, May 17, 2022 SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Releases 2021 Annual Shareholder Letter
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Ensysce Biosciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Exposures
Death
Intellectual Property
Legal
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
April 21, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from...
Via
FinancialNewsMedia
Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK
April 20, 2022
SAN DIEGO, CA / ACCESSWIRE / April 20, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer
April 18, 2022
SAN DIEGO, CA / ACCESSWIRE / April 18, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
March 24, 2022
SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Sets September 2021 Conference Schedule
August 31, 2021
SAN DIEGO, CA / ACCESSWIRE / August 31, 2021 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company with proprietary technology...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Exposures
Death
Intellectual Property
Legal
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.